Skip to main content
Clinical Trials/NCT03448133
NCT03448133WithdrawnNot Applicable

Repetitive Transcranial Magnetic Stimulation for the Treatment of Primary Progressive Aphasia: A Randomized Controlled Tria

Peking Union Medical College Hospital0 sitesStarted: March 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Primary Endpoint
Syntax comprehension Part of Bilingual Aphasia Battery( Standard modern Chinese version)

Study Overview

Brief Summary

The primary progressive aphasia (PPA) is a neurodegenerative condition characterized by a gradual, irreversible decline of language function (Mesulam, 2001). There are no known treatments for PPA so far. The relentless progression of PPA symptoms eventually leads to a profound impairment in communication ability and, ultimately, to more generalized deficits of cognition. Some cases and small studies reported that Transcranial Magnetic Stimulation (TMS), one of the non-invasive neuromodulation tech, can be employed to facilitate language production and improve the language ability in patients with PPA. Herein we will explore the tolerance and efficacy of TMS for the treatment of PPA by the randomized controlled trial .Meanwhile the functional MRI tech will be used to investigate the neural network changing in the procedure

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
35 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • All participants had also been evaluated previously by a behavioral neurologist at the Peking Union Medical College Hospital and had been clinically diagnosed with a variant of PPA.

Exclusion Criteria

  • Scored below 15 on the mini-mental state exam (MMSE) due to concerns that global cognitive impairment might preclude their ability to follow the directions and interfere with task performance.
  • Had a history of seizures or unexplained loss of consciousness, pregnancy, surgical breach of the skull, or any other medical or surgical contraindication to receiving noninvasive brain stimulation.
  • Is unable to complete the treatment and evaluations

Arms & Interventions

rTMS treatment group

Experimental

The participants will be devided into rTMS treatment and sham treatment by means of randomized methods.The protocol of treatment is to use rTMS with high frequency 10/20Hz 120%RMT 20 times for one month. The device is Magtism rTMS made in London, UK

Intervention: Magstim rTMS (Device)

sham treatment group

Sham Comparator

The control group is to receive sham treatment. The device is the same as the one used in the real treatment group.

Intervention: Magstim rTMS (Device)

Outcomes

Primary Outcomes

Syntax comprehension Part of Bilingual Aphasia Battery( Standard modern Chinese version)

Time Frame: One month(just after 20 times rTMS treatment)

Assessment of the grammar ability

Boston naming test evaluation

Time Frame: One month(just after 20 times rTMS treatment)

Assessment of the language production

Western Aphasia Battery(WAB) Speech fluency

Time Frame: One month(just after 20 times rTMS treatment)

Assessment of the language production

Repetition Part of WAB

Time Frame: One month(just after 20 times rTMS treatment)

Assessment of the repetition ability

Word recognition Part of WAB

Time Frame: One month(just after 20 times rTMS treatment)

Assessment of the reading

Boston naming test evaluation

Time Frame: Baseline

Assessment of the language production

Western Aphasia Battery(WAB) Speech fluency

Time Frame: Baseline

Assessment of the language production

Repetition Part of WAB

Time Frame: Baseline

Assessment of the repetition ability

Word recognition Part of WAB

Time Frame: Baseline

Assessment of the reading

Syntax comprehension Part of Bilingual Aphasia Battery( Standard modern Chinese version)

Time Frame: Baseline

Assessment of the grammar ability

Secondary Outcomes

  • fMRI parameters(strength, efficiency, clustering coefficient, and characteristic path length)(One month(just after 20 times rTMS treatment))
  • fMRI parameters(strength, efficiency, clustering coefficient, and characteristic path length)(Baseline)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials